CCL8 and sarcoma: With regard to the CCL8, the major difference in our results and the results from the other studies cited above is that, whereas in both breast carcinoma [76] and melanoma [77] this activating chemokine is provided by activated cancer stroma, this paracrine motility regulation switched to autocrine in our invasive sarcoma cells.